IRVINE, Calif./EWORLDWIRE/May 2, 2005 --- Cenomed, Inc. today announced that Floyd Benjamin (CEO, Keystone Pharmaceuticals, Inc.) has been appointed to Cenomed’s Board of Directors and that the two companies, Cenomed and Keystone, have entered into a strategic collaboration to develop and commercialize therapies for chemical defense and counter-terrorism.
